Company / Working Capital
Integra Lifesciences Holdings Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$703.6M
FY2025
5-year range
$159.6M / $840.6M
FY2021-FY2025
Trend
+341.0%
vs FY2024
Sector context
#49 of 160
Health Care
What the data says
Working Capital changed +341% YoY in FY2025, a notable deviation from the 9-year average annual change of +39%.
Based on SEC 10-K filings.
$704M in FY2025 with a 5-year CAGR of -3.4%.
Declined from $751M to $704M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#49 of 160 in Health CareTop 31% of 160This company $703.6M Sector average $757.1M
▼
-7.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, working capital increased 341.0% year-over-year.
- Ranks #49 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $703.6M | +341.0% |
| FY2024 | $159.6M | -78.8% |
| FY2023 | $751.1M | -10.7% |
| FY2022 | $840.6M | +3.3% |
| FY2021 | $813.7M | -2.7% |
| FY2020 | $836.2M | +58.7% |
| FY2019 | $526.9M | +2.8% |
| FY2018 | $512.5M | +8.3% |
| FY2017 | $473.2M | +27.4% |
| FY2016 | $371.6M | +24.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026